Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6ATAC42P is a **pseudogene** of the U6atac small nuclear RNA family, specifically designated as the 42nd such pseudogene. U6atac small nuclear RNAs are involved in the minor spliceosome, a complex responsible for the removal of rare U12-type introns from pre-mRNA transcripts. However, as a pseudogene, RNU6ATAC42P is a non-functional genomic remnant that arose from duplication or retrotransposition events. It is not known to produce a functional RNA or protein product, nor does it act as a receptor, enzyme, transporter, or other canonical therapeutic target. Like some pseudogenes, it may have the potential to modulate gene expression through antisense regulation or act as a source of regulatory RNAs if transcribed, but there is no direct evidence for biological function or disease relevance unique to RNU6ATAC42P. **Key points:** - **RNU6ATAC42P** is a **pseudogene**—a non-functional, typically non-expressed genomic DNA sequence related to a functional small nuclear RNA gene. - It is *not* a protein, receptor, enzyme, transporter, or validated therapeutic target. - There are no known drugs, therapeutic mechanisms, safety, or biomarker associations directly linked to this pseudogene. - Its main classification is as a **non-coding RNA pseudogene**; it does not encode a functional small nuclear RNA. - Alternative names are limited, as it is a pseudogene with a standardized nomenclature. This pseudogene should not be considered for drug targeting, therapeutic intervention, or biomarker use barring specific new evidence. Any reference to it as a target is likely due to a misinterpretation of gene classification nomenclature or sequence similarity to functional small nuclear RNAs.
Not applicable for drugs; for pseudogenes in general, possible regulatory effects via antisense transcripts or acting as competitive endogenous RNAs/miRNA sponges, but not specifically shown for this gene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 42, pseudogene (RNU6ATAC42P).